Diabetes — all decisions

The Board denied service connection for multiple conditions, including fatigue, bilateral eye disability, hypertension, diabetes mellitus, GERD, penile condition, left foot disability, and others. Some claims were remanded for further development.

The Board remands the claims for service connection for an endocrine disorder, to include diabetes, and obstructive sleep apnea (OSA) due to a need for additional evidence regarding potential exposures during service.

The Board granted service connection for bilateral hearing loss and an effective date of October 24, 2022, for obstructive sleep apnea. Other claims were denied or remanded.

The Board remands the issues for further development and readjudication by the AOJ.

The Board granted service connection for diabetic retinopathy, chronic kidney disease, a heart disability, erectile dysfunction, hypertension, a colon disability, major depressive disorder, and diabetes mellitus, type 2. The claims for PTSD, chronic kidney disease, diabetes mellitus, type 2, and hypertension were denied.

The Board denied service connection for diabetes mellitus and hypertension, but remanded claims for boils/cyst lower extremities/back, bilateral hearing loss, and left knee disorder.

The Board denied service connection for obesity and bilateral hearing loss, and remanded claims for hyperlipidemia, diabetes, GERD, hypertension, sleep apnea, erectile dysfunction, right knee disability, and right ankle disability due to secondary causes.

The Board granted earlier effective dates for service connection of focal mild squamous epithelial dysplasia and condylomatous changes with atypical squamous metaplasia post total abdominal hysterectomy, gallbladder cholecystectomy, cholecystectomy scar, hypothyroidism, and special monthly compensation (SMC) based on anatomical loss of creative organ. Service connection for diabetes mellitus type II (DMII) and anemia was also granted.

The Board granted service connection for type two diabetes mellitus, diabetic nephropathy (claimed as kidney disease), erectile dysfunction, bilateral lower extremity diabetic peripheral neuropathy, and hypertension, all found to be secondary to the Veteran's service-connected left knee disability.

The Board remands the claims for service connection for ischemic heart disease/cardiovascular disease, diabetes, and high blood pressure as further medical evidence is needed.

The Board remands the claims for service connection for various conditions, including an acquired psychiatric condition and diabetes, to ensure that all relevant VA treatment records are associated with the claims file.

The Board granted service connection for diabetes, left lower extremity peripheral neuropathy, and right lower extremity peripheral neuropathy due to exposure to herbicide agents during the Veteran's military service.

The appeals for service connection for chronic kidney disease, diabetes mellitus (DM), hypertension (HTN), hypothyroidism, and ischemic heart disease are dismissed due to the death of the Veteran.

The Board denied a rating higher than 40 percent for diabetes mellitus, granted a separate rating for hypertension as secondary to diabetes mellitus, and denied a compensable rating for hypothyroidism.

The Board remands the claims for service connection for hypertension and diabetes mellitus, type II, to correct duty to assist errors that occurred prior to the April 2025 rating decisions.

The Board denied the claims for increased rating and service connection as there was no evidence of a link between the Veteran's claimed conditions and his period of active service.

The Board granted service connection for diabetes mellitus type II (DM2) as secondary to the Veteran's service-connected PTSD.

The Board remands the claims for service connection for coronary artery disease and diabetes mellitus to correct a pre-decisional duty to assist error related to obtaining community care records.

The Board remands the claims for service connection for various conditions, including diabetes mellitus type 2 and peripheral neuropathy, to further investigate potential exposure to herbicides during the Veteran's service in Korea.

The Board remanded the claims for service connection for a bilateral eye disorder and type 1 diabetes mellitus, as well as denied the claim for service connection for hair loss.